The Washington Post on the labeling of cough medicines:
Autor said the unapproved products are made by some 100 manufacturers.
The FDA said it was particularly concerned about improper pediatric labeling of unapproved hydrocodone cough suppressants — also known as antitussives. None of the drugs that contain hydrocodone has been approved for children younger than 2 years old. “There are hydrocodone-containing products on the market that claim they are suitable for children as young as 2,” Autor said.
Also, many of the products don’t carry the proper warning label and often have similar names to other medications, creating a high risk of medication error, Autor said. “Product names are so similar that the wrong doses or wrong medication may be dispensed,” she said.
The full article is available here: FDA Cracks Down on Unapproved Cough Medicines.